Effects of dehydroepiandrosterone supplementation on mice with diminished ovarian reserve

Gynecol Endocrinol. 2018 Apr;34(4):357-359. doi: 10.1080/09513590.2017.1409712. Epub 2017 Dec 8.

Abstract

Dehydroepiandrosterone (DHEA) has been used to improve the pregnancy rate in women with diminished ovarian reserve(DOR) during in vitro fertilization. We aimed to validate the effects of DHEA and identify the possible mechanisms. We constructed a mice model with DOR and analyzed the hormone parameters and follicle counts. In vivo experiment, FSH and LH concentrations in the serum were significantly elevated in the DOR group. However, the FSH and LH concentrations were partially reversed in the DOR + DHEA group. The E2, AMH and INHB were down-regulated in the DOR group and reversed in the DOR + DHEA group. Our study supported evidences that DHEA might modulate the hormone receptors in the ovary and hormone secretions to the peripheral circulation to regulate the ovary reserve functions.

Keywords: Dehydroepiandrosterone; diminished ovarian reserve; follicle-stimulating hormone.

MeSH terms

  • Animals
  • Anti-Mullerian Hormone / blood
  • Dehydroepiandrosterone / pharmacology*
  • Female
  • Follicle Stimulating Hormone / blood*
  • Luteinizing Hormone / blood*
  • Mice
  • Ovarian Follicle / drug effects*
  • Ovarian Reserve / drug effects*
  • Therapeutics

Substances

  • Dehydroepiandrosterone
  • Anti-Mullerian Hormone
  • Luteinizing Hormone
  • Follicle Stimulating Hormone